1131617

Janssen Pharmaceuticals, Inc — FEI 2242843

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 28, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Titusville, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)